Melly Alazraki worked in the finance world, on both the buy and sell sides, before turning to writing about it. Her work has been featured in Daily Finance, Aol.com, MSN Money, The Motley Fool, BloggingStock, and 24/7 Wall St.
Melly initially wrote about general stock market and economics news before becoming a specialist, covering the pharmaceutical beat for Daily Finance. Several of her articles have been cited in papers published in Cornell University Press, Berkeley Technology Law Journal, University of Pennsylvania Law Review, and others.
Since joining 24/7 Wall St., Melly helped develop the site's data journalism side, focusing on economic, population trends, housing, and other topics.
Graduating with an honors commerce degree from the University of British Columbia, Melly uses her knowledge of economics, business, and experience to write data-supported pieces that aim to provide value and insight to readers.
China and the United States have a complicated relationship. The two countries are deeply connected economically, but they are also both competing for global influence. While the U.S. remains more dominant in…
Melly Alazraki For a while, it seemed that inflationary pressures may be easing, but recent reports suggest otherwise. Inflation remains stubbornly high, with the consumer price index rising by 3.1% annually in January, according…
Melly Alazraki In Jaipur India, a young expectant mother recently died after receiving the wrong blood type. The 23-year-old woman received the blood transfusion through SMS hospital, where she was given type A+ blood…
Melly Alazraki